Inducible CRISPR-Cas9

RQ Ryan J. Quinton
AD Amanda DiDomizio
MV Marc A. Vittoria
KK Kristýna Kotýnková
CT Carlos J. Ticas
SP Sheena Patel
YK Yusuke Koga
JV Jasmine Vakhshoorzadeh
NH Nicole Hermance
TK Taruho S. Kuroda
NP Neha Parulekar
AT Alison M. Taylor
AM Amity L. Manning
JC Joshua D. Campbell
NG Neil J. Ganem
ask Ask a question
Favorite

We infected cells with pCW-Cas9 plasmid (Addgene #50661) and selected cells with puromycin at 2 μg/mL. To improve knockout efficiency, cells were then infected with 2 distinct KIF18A sgRNA plasmids. Each sgRNA sequence was cloned into its own lenti-sgRNA-blast plasmid (Addgene #104993) and these plasmids were co-packaged into lentivirus and used to infect cells, which were then selected with blasticidin (Sigma) at 5μg/mL. The sequences for both KIF18A targeting sgRNAs are available in ref38:

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A